News Sentiment

BOLD sentiment intelligence

Boundless Bio, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.41 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-3.6% over one week, +70.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Jim Cramer just revealed his ‘favorite stock’

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -3.6% Price reacting lower
Trend fit Trend active 70.9% over four weeks
Fair value -13.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 39
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
TradingView 9
Market source 6
Finbold 3
Investing.com 3
Investing.com South Africa 3
StockStory 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 19
Deals and strategy 9
Analyst action 3
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 66
Investing.com Direct company coverage

Tang capital management, Kevin Tang buy $222k Boundless Bio stock

Tang Capital Management LLC and its manager Kevin Tang recently acquired $222,069 worth of Boundless Bio, Inc. (NASDAQ:BOLD) common stock between July 9 and July 13, 2026. These purchases involved 91,585 shares and increased their total beneficial ownership to 2,790,103 shares. T

Tone
Positive 59/100
Event
Market update
Published
14 Jul 2026 02:47
Source
Investing.com
Investing.com Nigeria Direct company coverage

Tang capital management, Kevin Tang buy $222k Boundless Bio stock By Investing.com

Tang Capital Management LLC and its sole manager, Kevin Tang, have purchased $222,069 worth of Boundless Bio (NASDAQ:BOLD) common stock between July 9 and July 13, 2026. This acquisition involved 91,585 shares at weighted-average prices ranging from $2.42 to $2.48, increasing Tan

Tone
Positive 65/100
Event
Deals and strategy
Published
14 Jul 2026 00:39
Source
Investing.com Nigeria
Investing.com Nigeria Direct company coverage

Form 4 Boundless Bio Inc For: 13 July By Investing.com

This article from Investing.com reports the filing of a Form 4 for Boundless Bio Inc. for July 13. The brief announcement provides no specific details from the Form 4 itself but mentions that the company's stock symbol is BOLD, which was down 0.82% at the time of publication.

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 00:16
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Ten percent owner of Boundless Bio (NASDAQ: BOLD) adds shares

Entities associated with Tang Capital Partners, a ten percent owner of Boundless Bio (NASDAQ: BOLD), purchased a total of 57,210 shares of common stock through open-market transactions between July 6 and July 8, 2026. These shares were bought at weighted-average prices ranging fr

Tone
Positive 71/100
Event
Market update
Published
09 Jul 2026 01:10
Source
Stock Titan
Investing.com Canada Direct company coverage

Kevin Tang’s Tang Capital buys $141,864 in Boundless Bio (BOLD) By Investing.com

Kevin Tang and Tang Capital Management LLC increased their investment in Boundless Bio (NASDAQ:BOLD) by purchasing $141,864 worth of shares between July 6 and July 8, 2026. These transactions occurred as Boundless Bio's stock has seen a significant surge, despite an InvestingPro

Tone
Positive 67/100
Event
Market update
Published
09 Jul 2026 00:13
Source
Investing.com Canada
Investing.com Canada Direct company coverage

Form 4 Boundless Bio Inc For: 6 July By Investing.com

This article from Investing.com announces the filing of Form 4 for Boundless Bio Inc for July 6th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders, such as officers, directors, and significant shareholders, within

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 22:11
Source
Investing.com Canada
Stock Titan Direct company coverage

ARCH funds, insiders trade 16,000 Boundless Bio (BOLD) shares

Entities associated with ARCH Venture funds and investment committee member Kristina Burow conducted insider trading activities involving Boundless Bio (BOLD) shares. On July 1, 2026, 16,000 shares were acquired through a cashless stock option exercise at $1.03 per share and subs

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 22:11
Source
Stock Titan
Investing.com Direct company coverage

Arch venture funds sell $39,840 in Boundless Bio stock

Several ARCH Venture Funds and Partners entities sold 16,000 shares of Boundless Bio, Inc. (NASDAQ:BOLD) common stock for $39,840 on July 1, 2026. This transaction followed a cashless exercise of stock options, with the shares acquired at $1.03 and immediately sold at $2.49. The

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 22:11
Source
Investing.com
Stock Titan Direct company coverage

16K Boundless Bio (BOLD) shares sold by ARCH funds post-exercise

ARCH-affiliated entities reported a cashless stock option exercise and subsequent sale of 16,000 Boundless Bio (BOLD) shares. The transaction, tied to director Kristina Burow's compensation, involved exercising options at $1.03 per share and selling the shares at $2.49 per share.

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 22:11
Source
Stock Titan
GlobeNewswire Direct company coverage

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of: Element Solutions Inc. (NYSE – ESI), Boundless Bio Inc. (Nasdaq – BOLD), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)

Brodsky & Smith LLC is investigating the proposed acquisitions of Element Solutions Inc. (NYSE – ESI), Boundless Bio Inc. (Nasdaq – BOLD), Nuvalent, Inc. (Nasdaq – NUVL), and Dana Incorporated (NYSE – DAN). The law firm reminds investors that there is no cost or financial obligat

Tone
Negative 34/100
Event
Deals and strategy
Published
06 Jul 2026 16:11
Source
GlobeNewswire
GuruFocus Direct company coverage

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Boundl

TANG CAPITAL MANAGEMENT LLC has acquired 2,533,845 shares of Boundless Bio Inc (NASDAQ: BOLD) for $2.60 per share, establishing a 0.33% position in the biotechnology company. Boundless Bio Inc is a clinical-stage oncology company developing cancer therapeutics targeting extrachro

Tone
Positive 63/100
Event
Deals and strategy
Published
04 Jul 2026 01:09
Source
GuruFocus
Investing.com UK Direct company coverage

Form 4 Boundless Bio Inc For: 2 July By Investing.com

This article from Investing.com is a standard financial news brief announcing a "Form 4" filing for Boundless Bio Inc. dated July 2nd. It does not provide further details about the filing but is presented within a typical Investing.com layout, including market data and related ne

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 11:10
Source
Investing.com UK
Investing.com South Africa Direct company coverage

Kevin Tang buys $268,880 of Boundless Bio (NASDAQ:BOLD) shares By Investing.com

Kevin Tang and Tang Capital Management LLC, significant owners of Boundless Bio (NASDAQ:BOLD), acquired common stock worth $268,880 through various transactions between June 30 and July 2, 2026. These purchases occurred at weighted-average prices ranging from $2.49 to $2.54, as t

Tone
Positive 66/100
Event
Market update
Published
03 Jul 2026 00:39
Source
Investing.com South Africa
Stock Titan Direct company coverage

Boundless Bio (BOLD) major holder buys 107,463 Common shares

Entities affiliated with Kevin Tang, a major holder in Boundless Bio (BOLD), purchased 107,463 shares of common stock through open-market transactions between June 30 and July 2, 2026. The purchases were made at prices ranging from $2.49 to $2.60 per share, increasing their total

Tone
Positive 71/100
Event
Market update
Published
02 Jul 2026 23:39
Source
Stock Titan
Stock Titan Direct company coverage

Tang Capital entities disclose 2.25M Boundless Bio (BOLD) shares in Form 3 filing

Entities affiliated with Tang Capital, managed by Kevin Tang, have disclosed an initial beneficial ownership of 2,247,512 shares of Boundless Bio (BOLD) common stock. This information was revealed in a Form 3 filing, which serves as an initial statement of ownership rather than a

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 21:40
Source
Stock Titan
Investing.com Direct company coverage

Tang Capital Management acquires $714,768 of Boundless Bio stock

Tang Capital Management LLC and its manager, Kevin Tang, acquired 286,333 shares of Boundless Bio (NASDAQ:BOLD) common stock worth $714,768 between June 25 and June 29, 2026. These transactions, at prices ranging from $2.47 to $2.56 per share, increase their total indirect owners

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 10:09
Source
Investing.com
Stock Titan Direct company coverage

Tang Capital-affiliated funds boost Boundless Bio (BOLD) stake with 286K-share buy

Funds affiliated with Tang Capital increased their stake in Boundless Bio (BOLD) by purchasing 286,333 shares between June 25-29, 2026. These open-market purchases were made at weighted-average prices generally ranging from $2.40 to $2.60 per share, through various Tang Capital l

Tone
Positive 71/100
Event
Deals and strategy
Published
30 Jun 2026 00:10
Source
Stock Titan
Investing.com South Africa Direct company coverage

Tang Capital Management acquires $714,768 of Boundless Bio stock By Investing.com

Tang Capital Management LLC, led by Kevin Tang, recently acquired 286,333 shares of Boundless Bio (NASDAQ: BOLD) common stock for $714,768 through multiple transactions between June 25 and June 29, 2026. These purchases were made at prices ranging from $2.47 to $2.56 per share, i

Tone
Positive 64/100
Event
Market update
Published
30 Jun 2026 00:10
Source
Investing.com South Africa
Stock Titan Direct company coverage

Tang-linked entities report 11.3% stake in Boundless Bio (NASDAQ: BOLD)

A Schedule 13G filing reveals that Tang Capital Management, Kevin Tang, and affiliated entities collectively beneficially own 11.3% of Boundless Bio (NASDAQ: BOLD), representing 2,533,845 shares. This passive investment indicates shared voting and dispositive power among the invo

Tone
Neutral 50/100
Event
Deals and strategy
Published
30 Jun 2026 00:10
Source
Stock Titan